Key Financial Data Of Reporting Company

TAKARA BIO INC. - Filing #7322771

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
27,043,000,000 JPY
43,505,000,000 JPY
57,280,000,000 JPY
78,142,000,000 JPY
50,398,000,000 JPY
67,699,000,000 JPY
33,885,000,000 JPY
46,086,000,000 JPY
21,984,000,000 JPY
34,565,000,000 JPY
Ordinary profit (loss)
3,853,000,000 JPY
3,405,000,000 JPY
17,444,000,000 JPY
20,682,000,000 JPY
25,063,000,000 JPY
28,459,000,000 JPY
11,495,000,000 JPY
14,159,000,000 JPY
4,008,000,000 JPY
6,347,000,000 JPY
Profit (loss)
2,899,000,000 JPY
14,313,000,000 JPY
18,485,000,000 JPY
8,681,000,000 JPY
2,623,000,000 JPY
Share capital
14,965,000,000 JPY
14,965,000,000 JPY
14,965,000,000 JPY
14,965,000,000 JPY
14,965,000,000 JPY
Total number of issued shares
120,415,600 xbrli:shares
120,415,600 xbrli:shares
120,415,600 xbrli:shares
120,415,600 xbrli:shares
120,415,600 xbrli:shares
Net assets
111,784,000,000 JPY
94,385,000,000 JPY
96,544,000,000 JPY
112,454,000,000 JPY
96,064,000,000 JPY
86,204,000,000 JPY
74,302,000,000 JPY
69,645,000,000 JPY
66,591,000,000 JPY
61,927,000,000 JPY
Total assets
121,252,000,000 JPY
100,320,000,000 JPY
108,607,000,000 JPY
129,202,000,000 JPY
115,712,000,000 JPY
101,386,000,000 JPY
89,750,000,000 JPY
81,124,000,000 JPY
75,009,000,000 JPY
68,045,000,000 JPY
Net assets per share
926.00
783.83
801.76
931.93
796.18
715.89
616.05
578.38
552.23
514.28
Dividend paid per share
17.00
42.00
33.00
16.00
8.00
Interim dividend paid per share
Basic earnings (loss) per share
24.08
12.30
118.87
132.97
153.51
164.84
72.10
79.29
21.79
31.72
Diluted earnings per share
Equity-to-asset ratio
0.920 xbrli:pure
0.941 xbrli:pure
0.889 xbrli:pure
0.869 xbrli:pure
0.829 xbrli:pure
0.850 xbrli:pure
0.827 xbrli:pure
0.859 xbrli:pure
0.887 xbrli:pure
0.910 xbrli:pure
Rate of return on equity
0.0304 xbrli:pure
0.0132 xbrli:pure
0.1566 xbrli:pure
0.1539 xbrli:pure
0.2372 xbrli:pure
0.2335 xbrli:pure
0.1320 xbrli:pure
0.1357 xbrli:pure
0.0430 xbrli:pure
0.0585 xbrli:pure
Price-earnings ratio
40.29 xbrli:pure
78.87 xbrli:pure
14.58 xbrli:pure
13.03 xbrli:pure
14.60 xbrli:pure
13.59 xbrli:pure
41.17 xbrli:pure
37.43 xbrli:pure
102.40 xbrli:pure
70.33 xbrli:pure
Payout ratio
0.706 xbrli:pure
0.353 xbrli:pure
0.215 xbrli:pure
0.222 xbrli:pure
0.367 xbrli:pure
Net cash provided by (used in) operating activities
1,711,000,000 JPY
36,897,000,000 JPY
6,985,000,000 JPY
13,943,000,000 JPY
6,339,000,000 JPY
Net cash provided by (used in) investing activities
-13,043,000,000 JPY
-6,693,000,000 JPY
-7,071,000,000 JPY
-3,778,000,000 JPY
-212,000,000 JPY
Net cash provided by (used in) financing activities
-5,233,000,000 JPY
-4,119,000,000 JPY
-2,070,000,000 JPY
-1,103,000,000 JPY
-946,000,000 JPY
Cash and cash equivalents
33,171,000,000 JPY
49,058,000,000 JPY
22,160,000,000 JPY
23,308,000,000 JPY
14,462,000,000 JPY
Number of employees
1,838 xbrli:pure
802 xbrli:pure
769 xbrli:pure
1,793 xbrli:pure
1,666 xbrli:pure
669 xbrli:pure
1,539 xbrli:pure
570 xbrli:pure
1,485 xbrli:pure
517 xbrli:pure
Total shareholder return
0.423 xbrli:pure
0.714 xbrli:pure
0.895 xbrli:pure
1.166 xbrli:pure
0.872 xbrli:pure
Total return on share price index
1.962 xbrli:pure
1.388 xbrli:pure
1.312 xbrli:pure
1.286 xbrli:pure
0.905 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.